Burgess Laura Hayley, Kramer Joan, Castelein Carley, Parra Joseph M, Timmons Victoria, Pickens Samantha, Fraker Sarah, Skinner C Cameron
HCA Healthcare, Clinical Operations Group, Nashville, TN.
VigiLanz Corporation, Minneapolis, MN.
HCA Healthc J Med. 2021 Dec 29;2(6):411-421. doi: 10.36518/2689-0216.1295. eCollection 2021.
Pharmacy-led medication reconciliation identifies and corrects medication errors that can potentially cause moderate to severe harm. This research sought to identify the impact of pharmacy-led medication reconciliation on patient outcomes and describe the changes in healthcare workers' perceptions of the program.
A pharmacy-led admission medication reconciliation program pilot started in July 2019, and a discharge medication reconciliation proof of concept was tested in September 2020 at a 432-bed hospital. The following periods were compared: August 2018 to February 2019 (pre-program implementation) and August 2019 to February 2020 (post-program implementation). Endpoints included patient outcomes, workforce productivity and interdisciplinary healthcare team satisfaction through program surveys. Patient outcomes were assessed with chisquared tests. Survey responses were assessed using the Likert scale. Descriptive statistics were used for productivity outcomes and the number of discharge medication reconciliations completed.
Approximately 18,000 admissions were recorded for each period. The adverse drug event (ADE) rate decreased 49% (p < 0.001), and the complication rate decreased 29.7% (p = 0.001). During post-pilot implementation, 6,530 medication histories were completed, and 70,050 medications were reviewed. Of medication histories completed, 22.6% of patient allergies/adverse drug reactions were updated, 52.3% of medications were clarified, and 54.7% of preferred outpatient pharmacies were updated. Pharmacy services completed medication histories in 38.8% of inpatients. In the proof of concept, 168 discharge medication lists were drafted. Survey results showed statistically significant improvement in healthcare team satisfaction.
A pharmacy-led medication reconciliation program involving designated pharmacists and pharmacy technicians has shown to decrease ADEs and complications while improving interdisciplinary healthcare team satisfaction.
由药剂师主导的用药核对可识别并纠正可能导致中度至重度伤害的用药错误。本研究旨在确定药剂师主导的用药核对对患者结局的影响,并描述医护人员对该项目看法的变化。
2019年7月启动了由药剂师主导的入院用药核对项目试点,并于2020年9月在一家拥有432张床位的医院对出院用药核对概念验证进行了测试。比较了以下时间段:2018年8月至2019年2月(项目实施前)和2019年8月至2020年2月(项目实施后)。终点指标包括通过项目调查得出的患者结局、劳动力生产率和跨学科医疗团队满意度。使用卡方检验评估患者结局。使用李克特量表评估调查回复。对生产率结局和完成的出院用药核对数量进行描述性统计。
每个时间段记录的入院人数约为18000例。药物不良事件(ADE)发生率下降了49%(p<0.001),并发症发生率下降了29.7%(p=0.001)。在试点实施后,完成了6530份用药史,审查了70050种药物。在完成的用药史中,22.6%的患者过敏/药物不良反应得到更新,52.3%的药物得到澄清,54.7%的首选门诊药房得到更新。药剂科服务为38.8%的住院患者完成了用药史。在概念验证中,起草了168份出院用药清单。调查结果显示跨学科医疗团队满意度有统计学意义的提高。
由药剂师主导、指定药剂师和药剂技术人员参与的用药核对项目已显示出可减少药物不良事件和并发症,同时提高跨学科医疗团队的满意度。